OTC Markets EXMKT - Delayed Quote USD

BIMI Holdings Inc. (BIMI)

Compare
0.0100 0.0000 (0.00%)
As of November 20 at 3:00 PM EST. Market Open.
Loading Chart for BIMI
DELL
  • Previous Close 0.0075
  • Open 0.0075
  • Bid --
  • Ask --
  • Day's Range 0.0075 - 0.0075
  • 52 Week Range 0.0075 - 4.1300
  • Volume 141
  • Avg. Volume 8,790
  • Market Cap (intraday) 139,607
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -6.3900
  • Earnings Date Nov 25, 2024 - Nov 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.

usbimi.com

296

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIMI

View More

Performance Overview: BIMI

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIMI
99.54%
S&P 500
24.02%

1-Year Return

BIMI
99.24%
S&P 500
30.09%

3-Year Return

BIMI
99.98%
S&P 500
25.92%

5-Year Return

BIMI
99.99%
S&P 500
90.31%

Compare To: BIMI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIMI

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    118.67k

  • Enterprise Value

    3.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.01

  • Enterprise Value/Revenue

    0.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -83.20%

  • Return on Assets (ttm)

    -13.01%

  • Return on Equity (ttm)

    -103.78%

  • Revenue (ttm)

    12.63M

  • Net Income Avi to Common (ttm)

    -10.52M

  • Diluted EPS (ttm)

    -6.3900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    994.13k

  • Total Debt/Equity (mrq)

    49.25%

  • Levered Free Cash Flow (ttm)

    -5.75M

Research Analysis: BIMI

View More

Company Insights: BIMI

Research Reports: BIMI

View More

People Also Watch